leah l. zullig - unc gillings school of global public health · leah l. zullig 411 west chapel hill...

L e a h L . Z u l l i g

411 West Chapel Hill Street, Suite 600 ■ Durham, North Carolina 27701 ■ [email protected]

EDUCATION

2013 PhD University of North Carolina, Chapel Hill, NC. Health Policy and Management, Gillings School of Global Public Health. Quality and Access concentration.

Dissertation title: “Equity in an Equal Access System? – Quality & Timeliness of Cancer Care in the Veterans Affairs Healthcare System”

Advisor: William R. Carpenter, PhD 2004 MPH East Tennessee State University, Johnson City, TN. College of Public Health. Public

Health Administration concentration. Magna cum laude.

Thesis title: “Scribe Feasibility Study: Transition from Paper to Electronic Health Records”

Advisor: J. Michael Stoots, EdD 2002 BS Appalachian State University, Boone, NC. Health Promotion major; Psychology minor Magna cum laude

PROFESSIONAL EXPERIENCE Current

2018– Associate Professor, Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC.

2017–2018 Assistant Professor, Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC.

2014–2017 Assistant Professor, Division of General Internal Medicine, Department of Medicine, Duke University, Durham, NC.

2014– Core Research Investigator, Durham Veteran Affairs Medical Center, Center for Health Services Research and Development (HSR&D) in Primary Care, Durham, NC.

2013– Adjunct Assistant Professor, University of North Carolina, Department of Health Policy and Management, Chapel Hill, NC.

Previous 2005–2013 Research Health Science Specialist, Durham Veteran Affairs Medical Center, Health

Services Research and Development (HSR&D), Durham, NC. 2011–2013 Pre-Doctoral Fellow, University of North Carolina, Cancer Care Quality Training

Program, Chapel Hill, NC. 2009–2011 Research Assistant and Teaching Assistant, University of North Carolina, Department

of Health Policy and Management, Chapel Hill, NC. 2005 Research Assistant, East Tennessee State University–Quillen College of Medicine,

Department of Family Medicine, Johnson City, TN. 2004–2005 Administrative Liaison, Medical Management Services, Inc., Johnson City, TN. 2003–2004 Graduate Assistant, East Tennessee State University, College of Public Health, Johnson

City, TN. 2002 Intern, Appalachian Cardiopulmonary Rehabilitation Program, Boone, NC.

SECONDARY APPOINTMENTS 2016– Duke Center for Applied Cancer Health Policy 2014– Duke Cancer Institute, Cancer Control and Population Sciences Program 2014– Duke AHEAD-Duke Academy for Health Professions Education & Academic

Development 2012–2013 Carolina Community Network


Revised July 2018

2 HONORS 2018 Carol Weisman and Gary Chase Gender Based Award, AcademyHealth. Seattle, WA. 2017 Delta Omega Honor Society Member, Theta Chapter. University of North Carolina;

Chapel Hill, NC. 2016–2017 Fellow of the Duke Department of Medicine Faculty Development Academy. Duke

University Medical School; Durham, NC. 2016 Inaugural Early Career Investigator Award. Duke University Medical School,

Division of General Internal Medicine; Durham, NC. 2014 Veterans Affairs (VA) Health Services Research and Development (HSR&D)

Career Development Award Recipient. 2013 Institute for Medical Research Young Investigator Poster Contest, 1st Place Winner.

Durham VA Medical Center; Durham, NC. 2011–2013 Pre-Doctoral Fellowship in Cancer Care Quality. University of North Carolina,

Department of Health Policy and Management, NCI-funded Cancer Care Quality Training Program; Chapel Hill, NC.

2007 Veterans Affairs Office of Quality Performance (OQP) Award bestowed for remarkable efforts in measuring the quality of treatment and surviellence for colorectal cancer patients within the Veterans Affairs healthcare system; Durham, NC.

2004 Magna cum laude. East Tennessee State University; Johnson City, TN. 2002 Magna cum laude. Appalachian State University; Boone, NC. PUBLICATIONS Refereed Articles In Press 1. Oshotse CO, Zullig LL, Bosworth HB, Tu P, Lin C. "Self-Efficacy and Adherence Behaviors in Rheumatoid

Arthritis (RA) Patients." [in press with Preventing Chronic Disease Journal]

2. Zullig LL, Kimmick G, Smith V, Little K, Bosworth HB, Gonzales S, Oakes MM, Shelby RA, Owen L, Altomare IP. "Using a Geriatric Oncology Assessment to Link with Services (GOAL).” [in press with Journal of Geriatric Oncology]

3. Zullig LL, Goldstein KM, Sims KJ, Williams CD, Chang M, Provenzale D, Kelley MJ. “Cancer among Women treated in the Veterans Affairs Health Care System.” [in press with Journal of Women’s Health]

4. De Geest S, Zullig LL, Dunbar-Jacob J, Helmy R, Hughes DA, Wilson IB, Vrijens B. “ESPACOMP Medication Adherence Reporting Guideline (EMERGE).” [in press with Annals of Internal Medicine]

5. Zullig LL, Blalock DV, Dougherty S, Henderson R, Ha C, Oakes MM, Bosworth HB. “The New Landscape of Medication Adherence Improvement: Where Population Health Science Meets Precision Medicine.” [in press with Patient Preference and Adherence]

6. Berkowitz CM, Allen DH, Tenhover J, Zullig LL, Fischer JE, Pollak KI, Hicks MR, Hillson JV, Koontz BF. "Needs of Head and Cancer Survivors: Implications for Survivorship Care Planning." [in press with Clinical Journal of Oncology Nursing]

7. Koczwara B, Stover AM, Davies L, Davis MM, Fleisher L, Ramanadhan S, Schroeck FR, Zullig LL,

Chambers DA, Proctor E. “Harnessing the Synergy between Improvement Science and Implementation Science in Cancer: a Call to Action.” [in press with Journal of Oncology Practice] PMID:29750579.


Revised July 2018

3 8. Zullig LL, Ramos K, Berkowitz C, Miller JJ, Dolor RJ, Koontz BF, Zafar SY, Allen DH, Tenhover JA,

Bosworth HB. “Assessing Key Stakeholders’ Knowledge, Needs, and Preferences for Head and Neck Cancer Survivorship Care Plans.” [in press with Journal of Cancer Education] PMID: 29526021.

9. Goldstein KM, Gierisch JM, Zullig LL, Alishahi A, Brearly T, Dedert EA, Raitz G, Sata SS, Whited JD,

Bosworth HB, McDuffie J, Williams JW. “Telehealth Services Designed for Women: An Evidence Map.” VA ESP Project #09-009; 2017.

10. Berkowitz C, Zullig LL, Koontz BF, Smith SK. "Prescribing an app? Oncology providers’ views on mobile

health apps for cancer care.” [in press with JCO Clinical Cancer Informatics]

11. Berkowitz C, Allen DH, Tenhover J, Zullig LL, Ragsdale J, Pollak KI, Koontz B. “Knowledge and preferences of primary care providers in delivering head and neck cancer survivorship care.” [in press with Journal Cancer Education] PMID: 28707205.

2018 12. Bosworth HB, Olsen MK, McCant F, Stechuchak KM, Danus S, Crowley MJ, Goldstein KM, Zullig LL,

Oddone EZ. “Telemedicine Cardiovascular Risk Reduction in Veterans: The CITIES trial.” American Heart Journal 2018 May;199:122-129. PMID: 29754649.

13. Zullig LL, Goldstein KM, Bosworth HB, Andrews SM, Danus S, Jackson GL, Provenzale P, Weinberger M, Kelley MJ, Voils CI. “Chronic Disease Management Perspectives of Colorectal Cancer Survivors Using the Veterans Affairs Healthcare System: A Qualitative Analysis.” BMC Health Services Research. 2018 Mar 9;18(1):171 PMID:29523146.

14. Bosworth HB, Ngouyombo B, Liska J, Zullig LL, Atlani C, Beal AC. “The Importance of Cholesterol Medication Adherence: The Need for Behavioral Change Intervention Programs.” Patient Preference and Adherence 2018 Mar 6;12:341-348. PMID: 29563777.

15. Zullig LL, McCant F, Silberberg M, Johnson F, Granger BB, Bosworth HB. “Changing CHANGE – Adaptations of an Evidence-Based Telehealth Cardiovascular Disease Risk Reduction Intervention.” Translational Behavioral Medicine. 2018 Mar 1;8(2):225-232. PMID: 29432589.

2017 16. Zullig LL, Diamantidis CJ, Bosworth HB, Bhapkar MJ, Barnhart H, Oakes MM, Pendergast JF, Miller JJ,

Patel UD. “Racial Differences in Nocturnal Dipping Status in Diabetic Kidney Disease (DKD): Results from the STOP-DKD Study.” Journal of Clinical Hypertension. 2017 Dec;19(12):1327-1335. PMID: 28834119.

17. Zullig LL, Goldstein KM, Bosworth HB. “Changes in the Delivery of Veterans Affairs (VA) Cancer Care: Ensuring Delivery of Coordinated, Quality Cancer Care in a Time of Uncertainty.” Journal of Oncology Practice. 2017 Nov;13(11):709-711. PMID: 28892409.

18. Zullig LL, Ramos K, Bosworth HB. “Improving medication adherence in coronary heart disease.” Current Cardiology Reports. 2017 Sep 22;19(11):113. PMID: 28940020.

19. Bosworth HB, Brown JN, Danus S, Sanders LL, McCant FM, Zullig LL, Olsen M. “An evaluation of a packaging approach to improve cholesterol medication adherence.” American Journal of Managed Care. 2017 Sep 1;23(9):e280-e286. PMID: 29087166.

20. Lin C, Clark R, Tu P, Bosworth HB, Zullig LL. “Breast cancer oral anti-cancer medication adherence: A systematic review of psychosocial motivators and barriers.” Breast Cancer Research and Treatment. 2017 Sep;165(2):247-260. PMID: 28573448.


Revised July 2018

4

21. Goldstein KM, Stechuchak KM, Zullig LL Oddone E, Olsen MK, McCant FM, Bastian LA, Batch BC, Bosworth HB. “Impact of gender on satisfaction and confidence in cholesterol control among veterans at risk for cardiovascular disease.” Journal of Women's Health. 2017 Jul;26(7):806-814. PMID: 28192012.

22. Zullig LL, Liang Y, Arismendez SV, Trevino A, Bosworth HB, Turner BJ. “Trajectory of systolic blood

pressure in a low-income, racial-ethnic minority cohort with diabetes and baseline uncontrolled hypertension.” Journal of Clinical Hypertension. 2017 Jul;19(7):722-730. PMID: 28371157.

23. Zullig LL, Sims KJ, McNeil R, Williams CD, Jackson GL, Provenzale D, Kelley MJ. “Cancer incidence

among patients of the United States Veterans Affairs (VA) healthcare system: 2010 update.” Military Medicine. 2017 Jul;182(7):e1883-e1891. PMID: 28810986.

24. Zullig LL, Mendys P, Bosworth HB. "Medication adherence: a practical measurement selection guide using

case studies.” Patient Education and Counseling. 2017 Jul;100(7):1410-1414. PMID: 28214168.

25. Whalley Buono E, Vrijens B, Bosworth HB, Liu LZ, Zullig LL, Granger BB. "Coming full circle in the measurement of medication adherence: opportunities and implications for healthcare.” Patient Preference and Adherence. 2017 Jun 2;11:1009-1017. PMID: 28652710.

26. Zullig LL, Wolf S, Vlastelica L, Shankaran V, Zafar SY. “The role of patient financial assistance programs (PAPs) in reducing costs for cancer patients.” Journal of Managed Care & Specialty Pharmacy. 2017 Apr;23(4):407-411. PMID: 28345445.

27. Helmy R, Zullig LL, Dunbar-Jacob J, Hughes DA, Vrijens B., Wilson IB, De Geest S. "ESPACOMP medication adherence reporting guidelines (EMERGE): a reactive-Delphi study protocol.” BMJ Open. 2017 Feb 10;7(2):e013496. PMID:28188154.

28. Bosworth HB, Fortmann SP, Kuntz J, Zullig LL, Mendys P, Safford M, Phansalkar S, Wang T, Rumptz MH. "Recommendations for providers on person-centered approaches to assess and improve medication adherence.” Journal of General Internal Medicine. 2017 Jan;32(1):93-100. PMID: 27599489

2016 29. Zullig LL, Smith VA, Jackson GL, Danus S, Schnell M, Lindquist J, Provenzale D, Weinberger M, Kelley

MJ, Bosworth HB. “Colorectal cancer statistics from the Veterans Affairs Central Cancer Registry.” Clinical Colorectal Cancer. 2016 Dec;15(4):e199-e204. PMID: 27301717

30. Check D, Reeder-Hayes K, Zullig L, Weinberger M, Basch E, Dusetzina S. “Examining racial variation in antiemetic use and post-chemotherapy health care utilization for nausea and vomiting among breast cancer patients.” Supportive Care in Cancer. 2016 Dec;24(12):4839-4847. PMID: 27465051

31. Williams CD, Grady WM, Zullig LL. “Use of NCCN, other guidelines, and biomarkers for colorectal cancer screening.” Journal of the National Comprehensive Cancer Network. 2016 Nov;14(11):1479-1485. PMID: 27799515

32. Goldstein KM, Zullig LL, Bastian LA, Bosworth HB. "Statin adherence: does gender matter?” Current Atherosclerosis Reports. 2016 Nov;18(11):63. PMID: 27696318

33. Zullig LL, Granger BB, Bosworth HB. “A renewed Medication Adherence Alliance call to action: harnessing

momentum to address medication non-adherence in the United States.” Patient Preference and Adherence. 2016 Jul 7;10:1189-95. PMID: 27462145


Revised July 2018

5

34. Nipp RD, Zullig LL, Samsa G, Peppercorn JM, Schrag D, Taylor DH, Abernethy AP, Zafar SY. “Identifying cancer patients who alter care or lifestyle due to treatment-related financial distress.” Psycho-Oncology. 2016 Jun;25(6):719-25. PMID: 26149817

35. Goldstein K, Zullig L, Bosworth H, Oddone E. “Consideration of out-of-office blood pressure monitoring in hypertension management.” Journal of Clinical Hypertension. 2016 May;18(5):381-2. PMID: 26541118

36. Shaw RJ, Pollak K, Zullig LL, Bennett G, Hawkins K, Lipkus I. “Feasibility and smokers’ evaluation of self-generated text messages to promote quitting.” Nicotine & Tobacco Research. 2016 May;18(5):1206-9. PMID: 26647104

37. Zullig LL, Schroeder K, Nyindo P, Namwai T, Silayo E, Moomba A, Munishi MO, Karia F, Muiruri C, Bartlett J, Maro V, Zafar SY. "Validation and quality assessment of the Kilimanjaro Cancer Registry.” Journal of Global Oncology. 2016 Apr 27;2(6):381-386. PMID: 28717724.

38. Check DK, Reeder-Hayes KE, Basch EM, Zullig LL, Weinberger M, Dusetzina SB. "Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer." Breast Cancer Research and Treatment. 2016 Apr;156(2):351-9. PMID: 26968396

39. Koczwara B, Birken SA, Perry C, Cragun D, Zullig LL, Ginnosar T, Nodora J, Chawla N, Ramanadhan S, Kerner J, Brownson RC. “How context matters – a dissemination and implementation primer for global oncologists.” Journal of Global Oncology. 2016 April; 2(2):51-55. PMID: 28717683

40. Bosworth HB, Zullig LL, Mendys P, Ho M, Trygstad T, Granger C, Oakes MM, Granger B. “Health information technology: meaningful use and next steps to improving electronic facilitation of medication adherence.” JMIR Medical Informatics. 2016 Mar 15;4(1):e9. PMID: 26980270

41. Zullig LL, Whitson HE, Hastings SN, Beadles C, Kravchenko J, Akushevich I, Maciejewski M. “A systematic review of conceptual frameworks of medical complexity and new model development.” Journal of General Internal Medicine. 2016 Mar;31(3):329-37. PMID: 26423992

42. Zullig LL, Fortune-Britt A (co-first authors), Rao S, Tyree SD, Godley PA, Carpenter WR. “Enrollment and racial disparities in National Cancer Institute cancer treatment clinical trials in North Carolina.” North Carolina Medical Journal. 2016 Jan-Feb;77(1):52-8. PMID: 26763244

2015 43. Zullig LL, Sanders LS, Thomas S, Brown JN, Danus S, McCant F, Bosworth HB. “Health beliefs and desire

to improve cholesterol levels among patients with hyperlipidemia.” Patient Education and Counseling. 2015 Nov 27. pii: S0738-3991(15)30141-5. PMID: 26673107

44. Ramalingam S, Pollak KI, Zullig LL, Harrison MR. “What should we tell patients about physical activity after a prostate cancer diagnosis?” Oncology. 2015 Sep 15;29(9). PMID: 26384805

45. Shaw RJ, Zullig LL, Crowley MJ, Grambow SC, Lindquist JH, Shah BR, Bosworth HB. “Willingness of patients to use computers for health communication and monitoring following myocardial infarction (MI).” CIN: Computers, Informatics, Nursing. 2015 Sep;33(9):384-9. PMID: 26176640

46. Zullig LL, Bosworth HB, Jeffreys AS, Corsino L, Coffman C, Oddone E, Yancy W, Allen K. “The association of comorbid conditions with patient reported outcomes in Veterans with hip and knee osteoarthritis.” Clinical Rheumatology. Aug;34(8):1435-41. PMID: 24916605


Revised July 2018

6

47. Jackson GL, Zullig LL, Phelan SM, Provenzale D, Griffin JM, Clauser SB, Haggstrom DA, Jindal RM, MD, van Ryn M. “Patient characteristics associated with the level of patient-reported care coordination among male colorectal cancer patients in the Veterans Affairs Healthcare System.” Cancer. 2015 Jul 1;121(13):2207-13. PMID: 25782082

48. Zullig LL, Stechuchak KM, Goldstein KM, Olsen MK, McCant FM, Danus S, Crowley MJ, Oddone EZ, Bosworth HB. “Patient-reported medication adherence barriers and medication adherence behavior among patients with cardiovascular risk factors.” Journal of Managed Care & Specialty Pharmacy. 2015 Jun;21(6):479-85. PMID: 26011549

49. Zullig LL, Bosworth HB. “Selecting, adapting, and sustaining programs in healthcare systems.” Journal of Multidisciplinary Healthcare. 2015 Apr 16;8:199-203. eCollection 2015. PMID: 25931825

50. Zullig LL, Shaw RJ, Shah BR, Peterson ED, Lindquist JH, Crowley MJ, Grambow SC, Bosworth HB. “Patient-provider communication, self-reported medication adherence, and race in a post-myocardial infarction population.” Patient Preference and Adherence. 2015 Feb 19;9:311-8. eCollection 2015. PMID: 25737633

51. Zullig LL, Gellad WF, Moaddeb J, Crowley MJ, Shrank W, Granger BB, Granger CB, Trygstad T, Liu LZ, Bosworth HB. “Improving diabetes medication adherence: successful, scalable interventions.” Patient Preference and Adherence. 2015 Jan 23;9:139-49. eCollection 2015. PMID: 25670885

52. Crowley MJ, Zullig LL, Shah BR, Shaw RJ, Lindquist JH, Peterson ED, Bosworth HB. “Medication non-

adherence after myocardial infarction: an exploration of modifying factors.” Journal of General Internal Medicine. 2015 Jan;30(1):83-90. PMID: 25361685

53. Zullig LL, Williams CD, Fortune-Britt AG. “Lung and colorectal cancer treatment and outcomes in the Veterans Affairs Healthcare System.” Cancer Management and Research. 2015 Jan 14;7:19-35. PMID: 25609998

2014 54. Shaw RJ, Steinberg D, Zullig LL, Bosworth HB, Johnson CM, Davis LL. “mHealth interventions for weight

loss: a guide for achieving treatment fidelity.” Journal of the American Medical Informatics Association. 2014 Nov-Dec;21(6):959-63. Epub 2014 May 22. PMID: 24853065

55. Zullig LL, Bosworth HB. “Behavioral interventions to improve hypertension control in the Veterans Affairs Healthcare System.” The Journal of Clinical Hypertension (Greenwich). J Clin Hypertens (Greenwich). 2014 Nov;16(11):827-37. PMID: 25294103

56. Bestvina CM, Zullig LL, Zafar SY. “The implications of out-of-pocket cost of cancer treatment in the USA: a

critical appraisal of the literature.” Future Oncology. 2014 Nov;10(14):2189-99. PMID: 25471033

57. Goldstein KM, Melnyk SD, Zullig LL, Stechuchak KM, Oddone E, Bastian LA, Rakley S, Olsen MK, Bosworth HB. “Heart matters: gender and racial differences in cardiovascular disease risk factor control among veterans.” Womens Health Issues. 2014 Sep-Oct;24(5):477-83. PMID: 25213741

58. Zullig LL, Pathman J, Melnyk SD, Brown JN, Sanders LL, Koropchak C, Howard T, Danus S, McCant F, Bosworth HB. “A protocol to evaluate the efficacy, perceptions, and cost of a cholesterol packaging approach to improve medication adherence.” Contemporary Clinical Trials. 2014 Sep;39(1):106-12. Epub 2014 Aug 10. PMID: 25117806


Revised July 2018

7 59. Mendys P, Zullig LL, Burkholder R, Granger B, Bosworth HB. “Medication adherence: process for

implementation.” Patient Preference and Adherence. 2014 Jul 28;8:1025-1034. eCollection 2014. PMID: 25114513

60. Bestvina CM, Zullig LL, Rushing C, Chino F, Samsa GP, Altomare I, Tulsky J, Ubel P, Schrag D, Nicolla J, Abernethy AP, Peppercorn J, Zafar SY. “Patient-oncologist cost communication, financial distress, and medication adherence.” Journal of Oncology Practice. 2014 May;10(3):162-7. PMID: 24839274

61. Zullig LL, Sanders LL, Shaw RJ, McCant F, Danus S, Bosworth HB. “A randomized clinical trial providing personalized cardiovascular risk information to initiate and maintain health behavior changes.” Journal of Telemedicine and Telecare. 2014;20(3):147-52. PMID: 24647384

62. Zullig LL, McCant F, Melnyk SD, Danus S, Bosworth HB. “A health literacy pilot intervention to improve medication adherence using Meducation® technology.” Patient Education and Counseling. 2014 May;95(2):288-91. PMID: 24629834

63. Zullig LL, Vanderburg SB, Muiruri C, Abernethy A, Weiner BJ, Bartlett JA, Oneko O, Lisasi E, Oresto M, Zafar SY. “Sustainability of cancer registration in the Kilimanjaro region of Tanzania - a qualitative assessment.” World Health & Population. 2014;15(1):21-30. PMID: 24702763

64. Zullig LL, Jackson GL, Provenzale D, Griffin JM, Phelan S, Nieuwsma JA, van Ryn, M. “Utilization of hospital-based chaplain services among newly diagnosed Veterans Affairs colorectal cancer patients.” Journal of Religion and Health. 2014 Apr;53(2):498-510. PMID: 23054482

65. Van Ryn M, Phelan SM, Arora NK, Haggstrom DA, Jackson GL, Zafar SY, Griffin JM, Zullig LL, Provenzale D, Yeazel MW, Jindal RM, Clauser SB. “Patient-reported quality of symptom management among colorectal cancer patients in the Veterans Affairs Health Care System.” Journal of Clinical Oncology. 2014 Mar 10;32(8):809-15. PMID: 24493712

66. Zullig LL, Melnyk SD, Stechuchak KM, McCant F, Danus S, Oddone E, Bastian L, Olsen M, Edelman D,

Rakley S, Morey M, Bosworth HB. “The Cardiovascular Intervention Improvement Telemedicine Study (CITIES): rationale for a tailored behavioral and educational pharmacist-administered intervention for achieving cardiovascular disease risk reduction.” Telemedicine and e-Health. 2014 Feb;20(2):135-43. PMID: 24303930

2013 67. Zullig LL, Jackson GL, Weinberger M, Provenzale D, Reeve BB, Carpenter WR. “An examination of racial

differences in process and outcome of colorectal cancer care quality among users of the Veterans Affairs Health Care System.” Clinical Colorectal Cancer. 2013 Dec;12(4):255-60. PMID: 23988481

68. Zullig LL, Peppercorn J, Schrag D, Taylor D, Lu Y, Samsa G, Abernethy A, Zafar SY. “Financial distress,

utilization of cost-coping strategies, and adherence to prescription medication among cancer patients.” Journal of Oncology Practice. 2013 Nov:60s-63s. PMID: 23981344

69. Zullig LL, Shaw RJ, Crowley M, Lindquist J, Grambow S, Peterson E, Bimal S, Bosworth HB. “The association between perceived life chaos and medication adherence in a post-myocardial infarction population.” Circulation: Cardiovascular Quality Outcomes. 2013 Nov 1;6(6):619-25. PMID: 24221839

70. Zullig LL, Carpenter WR, Provenzale D, Weinberger M, Reeve BB, Jackson GL. “Examining potential colorectal cancer care disparities in the Veterans Affairs Healthcare System.” Journal of Clinical Oncology. 2013 Oct 1;31(28):3579-84. PMID: 24002515


Revised July 2018

8 71. Shaw RJ, Kaufman MA, Bosworth HB, Weiner BJ, Zullig LL, Lee SD, Kravetz JD, Rakley SM, Roumie CL,

Bowen ME, Del Monte PS, Oddone EZ, Jackson GL. “Organizational factors associated with readiness to implement and translate a primary care based telemedicine behavioral program to improve blood pressure.” Implementation Science. 2013 Sep 8;8(1):106. PMID: 24010683

72. Zullig LL, Melnyk SD, Goldstein K, Shaw RJ, Bosworth HB. “The role of home blood pressure

telemonitoring in managing hypertensive populations.” Current Hypertension Reports. 2013 Aug;15(4):346-55. PMID: 23625207

73. Zullig LL, Carpenter WR, Provenzale DT, Weinberger M, Reeve BB, Williams CD, Jackson GL. “The association of race with timeliness of care and survival among Veterans Affairs Healthcare System patients with late-stage non-small cell lung cancer.” Cancer Management and Research. 2013 Jul 24;5:157–63. PMID: 23900515

74. VanderWalde NA, Meyer AM, Liu H, Tyree SD, Zullig LL, Carpenter WR, Shores CG, Weissler MC, Hayes DN, Fleming M, Chera BS. “Patterns of care in older patients with squamous cell carcinoma of the head and neck: a Surveillance Epidemiology and End Results-Medicare analysis.” Journal of Geriatric Oncology. 2013 Jul;4(3):262-270. PMID: 24058388

75. Jackson GL, Zullig LL, Zafar SY, Powell AA, Ordin DL, Gellad ZF, Abbott DH, Schlosser JM, Hersh J, Provenzale DT. “Using NCCN practice guidelines to measure the quality of colorectal cancer care in the Veterans Health Administration.” Journal of the National Comprehensive Cancer Network. 2013 Apr 1;11(4):431-441. PMID: 23584346

76. Melnyk SD, Zullig LL, McCant F, Danus S, Oddone E, Bastian L, Olsen M, Stechuchak KM, Edelman D, Rakley S, Morey M, Bosworth HB. “Telemedicine cardiovascular risk reduction intervention in Veterans.” American Heart Journal. 2013 Apr;165(4):501-8. PMID: 23537965

77. Zullig LL, Muiruri C, Abernethy A, Weiner BJ, Bartlett JA, Oneko O, Zafar SY. “Cancer registration needs assessment at a tertiary medical center in Kilimanjaro, Tanzania.” World Health & Population. 2013;14(2):12-23. PMID: 23713208

78. Zafar SY, Malin JL, Grambow SC, Abbott DH, Kolimaga JT, Zullig LL, Weeks JC, Ayanian JZ, Kohn KL,

Ganz PA, Catalano P, West DW, Provenzale D. “Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort study.” Cancer. 2013 Feb 15;119(4):854-62. PMID: 22972673

79. Williams CD, Stechuchak K, Zullig LL, Provenzale D, Kelley MJ. “Influence of comorbidity on racial

differences in receipt of surgery among US veterans with early-stage non-small cell lung cancer.” Journal of Clinical Oncology. 2013 Feb 1;31(4):475-81. PMID: 23269988

80. Phelan S, Griffin J, Jackson G, Yousuf S, Hellerstedt W, Stahre M, Nelson D, Zullig L, Burgess DJ, van Ryn

M. “Stigma, perceived blame, self-blame, and depressive symptoms in men with colorectal cancer.” Psycho-Oncology. 2013 Jan;22(1):65-73. PMID: 21954081

2012 81. Wheeler SB, Zullig LL, Jungerwirth R, Reeve BB, Buga GA, Morroni C. “Knowledge of termination of

pregnancy (TOP) legislation and attitudes toward TOP clinical training among medical students in South Africa.” World Health & Population. 2012;14(1):5-18. PMID: 23135069

82. Wheeler SB, Zullig LL, Reeve BB, Buga GA, Morroni C. “Attitudes towards and intentions to provide

termination of pregnancy (TOP) services among medical students in South Africa.” International Perspectives on Sexual and Reproductive Health. 2012 Sep;38(3):154-63. PMID: 23018137


Revised July 2018

9 83. Carpenter WR, Tyree S, Wu Y, Meyer AM, DiMartino L, Zullig L, Godley PA. “A surveillance system for

monitoring, public reporting, and improving minority access to cancer clinical trials.” Clinical Trials. 2012;9(4):426-35. PMID: 22761398

84. Sanoff HK, Carpenter WR, Freburger J, Li L, Chen K, Zullig LL, Goldberg RM, Schymura MJ, Schrag D. “Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a Population-based analysis.” Cancer. 2012 Sept 1;118(17):4309-20. PMID: 22294436

85. Zullig LL, Jackson GL, Dorn RA, McNeil R, Thomas C, Provenzale DT, Kelley MJ. “Cancer incidence among patients of the United States Veterans Affairs (VA) Healthcare System.” Military Medicine. 2012 Jun;177(6):693-701. PMID: 22730846

86. Zullig LL, Jackson GL, Provenzale D, Griffin JM, Phelan S, van Ryn M. “Transportation: a vehicle or

roadblock to cancer care for VA patients with colorectal cancer?” Clinical Colorectal Cancer. Mar 2012;11(1):60-65. PMID: 21803001

87. Carpenter WR, Fortune-Greeley AK, Zullig LL, Lee SY, Weiner BJ. “Sustainability and performance of the

National Cancer Institute's Community Clinical Oncology Program.” Contemporary Clinical Trials. Jan 2012;33(1):46-54. PMID: 21986391

2011 88. Zafar SY, Malin JL, Grambow SC, Abbott DH, Schrag D, Kolimaga JT, Zullig LL, Weeks JC, Fouad MN,

Ayanian JZ, Wallace R, Kahn KL, Ganz PA, Catalano P, West DW, Provenzale DT. “Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study.” BMC Cancer. 2011;11:354. PMID: 21846341

89. Hamilton NS, Jackson GL, Abbott DH, Zullig LL, Provenzale D. “Use of psychosocial support services

among male Veterans Affairs colorectal cancer patients.” Journal Psychosocial Oncology. May 2011;29(3):242-253. PMID: 21590571

2010 90. Jackson GL, Powell AA, Ordin, DL, Schlosser JE, Murawsky J, Hersh J, Ponte G, Zullig LL, Erb F, Parlier

R, Haggstrom DA, Koets N, Mills PD, Francis J, Kelley MJ, Davies ML, Provenzale D. “Developing and sustaining quality improvement partnerships in the VA: the Colorectal Cancer Care Collaborative.” Journal General Internal Medicine. Jan 2010;25 Suppl 1:38-43. PMID: 20077150

91. Jackson GL, Melton LD, Abbott DH, Zullig LL, Ordin DL, Grambow SC, Hamilton NS, Zafar SY, Gellad

ZF, Kelley MJ, Provenzale D. “Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs.” Journal Clinical Oncology. Jul 1 2010;28(19):3176-3181. PMID: 20516431

92. Fisher DA, Zullig LL, Grambow SC, Abbott DH, Sandler RS, Fletcher RH, El-Serag HB, Provenzale D.

“Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System.” Digestive Diseases and Sciences. May 2010;55(5):1434-1441. PMID: 20238248

2009 93. Chao HC, Schwartz AR, Hersh J, Hunnibell L, Jackson GL, Provenzale DT, Schlosser J, Stapleton LM,

Zullig LL, Rose, MG. “Improving colorectal cancer screening and care in the Veterans Affairs Healthcare system.” Clinical Colorectal Cancer. Jan 2009;8(1):22-28. PMID: 19203893

94. Zafar SY, Abernethy AP, Abbott DH, Grambrow SC, Marcello JE, Herndon JE, Rowe KL, Kolimaga JT, Zullig LL, Patwardhan MB, Provenzale DT. “Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems.” BMC Cancer. 2008;8:345. PMID: 19032772


Revised July 2018

10 Book Chapters 1. Zullig LL, Shaw RJ, Bosworth HB. "Applying Technology to Medication Management and Adherence."

Behavioral Health Care and Technology: Using Science Based Innovations to Transform Practice, 1st Ed. Ed. Lisa Marsch, Sarah Lord, Jesse Dallery. New York: Oxford University Press. 2014. 81-94.

2. Oshotse CO, Bosworth HB, Zullig LL. “Treatment Engagement and Adherence: A Review of the Literature.” Handbook of Patient Engagement in Healthcare Treatment: Theory, Research and Clinical Practice, 1st Ed. Ed. Andrew Hadler, Lars Osterberg, Stephen Sutton. John Wiley & Sons Ltd: Baffins Lane, Chichester, West Sussex PO19 IUD, England.

3. Zullig LL, Williams CD, Cohen HJ. “Aging and Cancer Survivorship.” Handbook of Cancer Survivorship, 2nd Ed. Ed. Michael Feuerstein, Larissa Nekhlyudov. New York: Springer.

Refereed Editorials and Commentaries 1. Zullig LL, Bosworth HB. “Importance and challenges of moving stroke prevention into the

community.” Circulation: Cardiovascular Quality and Outcomes. 2018 Jan;11(1):e004513. PMID: 29321136.

2. Zullig LL, Curtis LH. “A population health perspective on a claims and electronic health record–based tool to screen for suboptimal medication adherence.” American Heart Journal. 2018 Mar;197:150-152. PMID: 29447775.

3. Zullig LL, Carpenter WR, Williams CD. “Next Steps to Improve Disparities in Lung Cancer Treatment Clinical Trial Enrollment.” Annals of Translational Medicine. 2017 Mar;5(5):118. PMID: 28361083.

4. Zullig LL, Peterson ED, Bosworth HB. “Strategies to overcome medication nonadherence--reply.” JAMA. 2014 Apr 23-30;311(16):1693-4. PMID: 24756525

5. Zullig LL, Peterson E, Bosworth HB. “Ingredients of successful interventions to improve medication adherence.” JAMA. 2013 Dec 25;310(24):2611-2. PMID: 24264605

6. Zullig, LL, Bosworth BB. "Engaging patients to optimize medication adherence." NEJM Catalyst. 2017

March; Available from http://catalyst.nejm.org/optimize-patients-medication-adherence.

Unrefereed Commentaries and Editorials 1. Zullig LL. “How can research impact patients’ health in the ‘real world’?” OUPblog, Oxford University

Press. May 24, 2018. https://blog.oup.com/2018/05/research-impact-patients-health-real-world/.

2. Zullig L and Zafar SY. (2013, Dec. 2). “Commentary: the financial distress of a cancer diagnosis.” Retrieved December 4, 2013, from https://cancerkn.com/thefinancialdistressofacancerdiagnosis/.

Published Abstracts 2017 1. Zullig LL, Lindquist J, Smith VA, Williams CD, Weinberger M, Provenzale D, Jackson GL, Kelley MJ,

Danus S, Bosworth HB. “Hypertension among Veterans Affairs colorectal cancer survivors: a matched case-control analysis.” Federal Practitioner. 2017 August;34(suppl 6).

2. Berkowitz C, Allen, DH, Tenhover J, Zullig LL, Fischer JE, Pollak KI, Hicks MR, Hillson JV, Koontz BF. “Survivorship needs after head and neck cancer treatment.” Journal of Clinical Oncology. 2017 35:15 suppl, 10062-10062.


Revised July 2018

11 2016 3. Zullig LL, Sims KJ, McNeil RB, Williams C, Jackson GL, Provenzale D, Kelley MJ. "Cancer incidence in

the Veterans Affairs Healthcare System: a Veterans Affairs Central Cancer Registry analysis.” Federal Practitioner. 2016 September;33 (supp 8):18S.

4. Silva A, Henry E, Zullig LL, Crawford R, Faricy-Anderson K, Klein MA, Houranieh J. "Treatment patterns among men with metastatic castrate-resistant prostate cancer within the United States Veterans Affairs Health System.” Federal Practitioner. 2016 September;33 (supp 8):27S-28S.

5. Zullig LL, Muiruri M, Nyindo P, Namwai T, Karia F, Oresto M, Silayo E, Msomba A, Bartlett J, Zafar SY. Abstract 266: “Validation and quality assessment of the Kilimanjaro Cancer Registry.” Journal of Clinical Oncology. 34, 2016 (suppl 7S; abstr 266).

6. Check D, Reeder-Hayes KE, Basch EM, Zullig LL, Weinberger M, Dusetzina SB. Abstract 292: "Investigating racial disparities in use of neurokinin-1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among Medicare beneficiaries with breast cancer." Journal of Clinical Oncology. 34, 2016 (suppl 7S; abstr 292).

2015 3. Zullig LL, Smith VA, Danus S, Schnell M, Lindquist J, Provenzale D, Jackson GL, Weinberger M, Kelley

MJ, Bosworth HB. Abstract 157298: “Colorectal cancer survivorship statistics: a Veterans Affairs Central Cancer Registry analysis.” Journal of Clinical Oncology. (suppl 3S; abstr e267).

4. Zullig LL, Stechuchak K, Goldstein KM, Olsen M, McCant FA, Danus SM, Crowley M, Oddone E,

Bosworth H. “Patient-reported medication adherence barriers among Veterans Affairs patients with cardiovascular risk factors.” Journal of General Internal Medicine. 30: S224-S224. Apr 2015.

2014 5. Zullig LL, Rushing C, Chino F, Samsa G, Altomare I, Tulsky J, Ubel P, Nicolla J, Abernethy AP, Peppercorn

J, Zafar SY. Abstract 6615: “Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision-making?” Journal of Clinical Oncology. 32:5s, 2014 (Suppl; Abstr 6615).

6. Zullig LL, McCant F, Melnyk SD, Danus S. “A health literacy intervention to improve medication adherence using Meducation technology.” Journal of General Internal Medicine. 29: S8-S9. Apr 2014.

7. Goldstein KM, Melnyk SD, Zullig LL, Stechuchak K, Oddone EZ, Bastian LA, Rakley S, Olsen M, Bosworth H. “Gender and racial differences in control of cardiovascular disease risk factors among Veterans.” Journal of General Internal Medicine. 29: S103-S103. Apr 2014.

2013 8. Bestvina C, Zullig LL, Rushing C, Chino F, Samsa G, Altomare I, Tulsky J, Ubel P, Schrag D, Nicolla J,

Abernethy A, Peppercorn J, Zafar SY. Abstract 2: “Patient-oncologist cost communication, financial distress, and medication ddherence.” Journal of Clinical Oncology. 31, 2013 (Suppl 31; Abstr 2).

9. Zullig LL, Jackson GL, Weinberger M, Provenzale D, Reeve BB, Carpenter WR. Abstract 6555: “Are there racial differences in colorectal cancer care timeliness among users of the Veterans Affairs Healthcare System?” Journal of Clinical Oncology. 31, 2013 (Suppl; Abstr 6555).

2012 10. Zullig LL, Peppercorn J, Schrag D, Taylor D, Zhong, X, Samsa G, Abernethy A, Zafar SY. Abstract 57:

“copayment assistance and adherence to prescription medication among cancer patients.” Journal of Clinical Oncology. 30, 2012 (Suppl 34; Abstr 57).


Revised July 2018

12

11. Zullig LL, Carpenter WR, Abbott DH, Provenzale DT, Weinberger M, Reeve BB, Jackson GL. Abstract 229: “Examining potential cancer care disparities in an equal access system – quality of colorectal cancer care (CRC) in the Veterans Affairs (VA) Healthcare System.” Journal of Clinical Oncology. 30, 2012 (Suppl 34; Abstr 229).

12. Zullig LL, Vanderburg S, Johnson D, Oneko O, Muiruri C, Ntabaye M, Abernethy AP, Bartlett J, Zafar SY.

Abstract 6102: “Assessment of cancer registries (CR) in low and middle-income countries (LMCs).” Journal of Clinical Oncology. 30, 2012 Suppl:6102.

13. VanderWalde NA, Meyer AM, Zullig LL, Tyree SD, Carpenter WR, Weissler MC, Shores CG, Hayes DN,

Chera BS. Abstract 5539: “Patterns of care in elderly patients with squamous cell carcinoma of the head and neck: a SEER-Medicare analysis.” Journal of Clinical Oncology. 30, 2012 Suppl:5539.

2011 14. Godley PA, Carpenter WR, Edwards LJ, Talcott JA, Zullig LL, Peacock S, Schenck AP. Abstract PL04-02:

“Efficacy of PSA screening for prostate cancer: A case-control study of Caucasian and African American Medicare beneficiaries.” Cancer Epidemiology Biomarkers & Prevention. Sept 2011; Vol 20, Issue 10, Suppl 1.

2009 15. Provenzale DP, Jackson GL, Zullig LL, Paynter BK, Khwaja R, Gellad ZF, Ordin D. Abstract M1035: “The

colorectal cancer quality measurement system (CCQMS).” Gastroenterology. 2009; 136(5), A-336, May 2009.

16. Zafar SY, Grambow SC, Abbott DH, Malin JL, Zullig LL, Kolimaga JT, Provenzale DT, and the CanCORS

Steering Committee. Abstract 6519: “Factors associated with chemotherapy receipt and intensity for stage IV colorectal cancer (CRC): a multi-health system, population-based study.” Journal of Clinical Oncology. 27:15s, 2009 Suppl; 6519.

2008 17. Zafar SY, Abernethy AP, Abbott DH, Grambrow SC, Marcello JE, Herndon JE, Rowe KL, Kolimaga JT,

Zullig LL, Patwardhan MB, Provenzale DT. “Comorbidity, age, race and stage at diagnosis in colorectal cancer: a retrospective, parallel analysis of two health systems.” BMC Cancer. 2008;8:345.

18. Zafar SY, Grambow SC, Abbott DH, Schrag D, Kolimaga JT, Zullig-Conner L, Weeks JC, Provenzale DT. Abstract 6562: “Use of bevacizumab after U.S. Food and Drug Administration (FDA) approval for first-line metastatic colorectal cancer (mCRC): a Cancer Outcomes Research & Surveillance Consortium (CanCORS) study.” Journal of Clinical Oncology. 26:2008 Suppl; 6562.

19. Fisher DA, Zullig-Conner L, Grambow SC, Abbott DH, Provenzale DT. Abstract 1008: “Time to diagnosis

of colorectal cancer in the VA System.” Gastroenterology. 2008; 134(4), A-152. 2007 20. Zafar SY, Abernethy AP, Abbott DH, Herndon JE, Rowe K, Kolimaga JT, Zullig-Conner L, Patwardhan

MB, Grambow SC, Provenzale DT. Abstract 6554: “Comorbidity, age and stage at diagnosis in colorectal cancer (CRC).” Journal of Clinical Oncology. 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 6554


Revised July 2018

13 ABSTRACTS, ORAL, AND POSTER PRESENTATION (*refereed) 2018 1. *Zullig LL, Kimmick G, Smith V, Little K, Bosworth HB, Gonzales S, Oakes MM, Shelby RA, Owen L,

Sutton L, Altomare IP. Online Only: “Using a Geriatric Oncology Assessment to Link with Services in an Underserved, Community Oncology Population.” American Society of Clinical Oncology Annual Meeting. Chicago, IL. June 2018.

2. *Goldstein KM, Zullig LL, Alishahi A, Brearly T, Dedert EA, Raitz G, Sata SS, Whited JD, Bosworth HB, Williams JW, Gierisch JM. Oral: "Telehealth Services Designed for Women: An Evidence Map." AcademyHealth Annual Meeting. Seattle, WA; June 2018. Winner, AcademyHealth Carol Weisman and Gary Chase Gender Based Award.

3. Ramos K, Zullig LL, Berkowitz C, Miller JJ, Dolor R, Koontz B, Zafar SY, Allen DH, Tenhover J, Bosworth HB. Poster: “Assessing Key Stakeholders’ Knowledge, Needs, and Preferences for Head and Neck Cancer Survivorship Care Plans.” Duke Cancer Control Population Sciences Research Poster Fair. Durham, NC; May 2018.

4. *Goldstein KM, Zullig LL, Alishahi-Tabriz A, Brearly T, Dedert EA, Raitz G, Sata SS, Whited JD, Bosworth HB, Williams JW, Gierisch JM. Oral: “Telehealth Services Designed for Women: An Evidence Map.” Society for General Internal Medicine Annual Meeting. Denver, CO; April 2018.

5. *Zullig LL, Smith VA, Lindquist JH, Williams CD, Weinberger M, Provenzale D, Jackson GL, Kelley MJ, Danus S, Bosworth HB. Poster: “Cardiovascular Disease-Related Chronic Conditions among Veterans Affairs Colorectal Cancer Survivors: A Matched Case-Control Analysis.” American Society of Clinical Oncology Cancer Survivorship Symposium. Orlando, FL; February 2018.

6. *Zullig LL, Berkowitz C, Miller J, Ramos K, Dolor R, Koontz B, Zafar SY, Allen DH, Tenhover J, Bosworth HB. Poster: “Assessing Key Stakeholders’ Knowledge, Needs, and Preferences for Cancer Survivorship Care Plans.” American Society of Clinical Oncology Cancer Survivorship Symposium. Orlando, FL; February 2018.

2017 7. *Zullig LL, McCant F, Silberberg M, Johnson F, Granger BB, Bosworth HB. Poster: “Changing CHANGE –

adaptations of an evidence-based telehealth cardiovascular disease risk reduction intervention.” Science of Dissemination and Implementation Annual Meeting. Washington, DC; December 2017.

8. *Muiruri C, Okeke NL, Zullig LL, Mkumba L, Paul JE, Weinberger M, Bennett AV, Holmes M, Bartlett JA. Oral: “Does having a Primary Care Provider improve the quality of primary cardiovascular disease prevention for People Living with HIV?” HIV and Aging: From the Mitochondria to the Metropolis. Decatur, GA; November 2017.

9. *Muiruri C, Zullig LL, Okeke NL, Paul JE, Weinberger M, Bennett AV, Bartlett JA, Holmes M. Poster: “Differences in prescription patterns for secondary prevention of cardiovascular disease for people living with HIV.” HIV and Aging: From the Mitochondria to the Metropolis. Decatur, GA. November 2017.

10. *Zullig LL, Lindquist J, Smith VA, Williams CD, Weinberger M, Provenzale D, Jackson GL, Kelley MJ, Danus S, Bosworth HB. Poster: “Hypertension among Veterans Affairs colorectal cancer survivors: a matched case-control analysis.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Denver, CO; September 2017. Winner, 3nd Place Abstract.


Revised July 2018

14

11. *Zullig LL, Kimmick G, Little K, Bosworth HB, Gonzales S, Oakes MM, Shelby RA, Owen L, Smith V, Altomare IP. Poster: "Use of a geriatric screener to identify resource needs in a community-based oncology practice: work in progress.” Internal Society of Geriatric Oncology Annual Meeting. Warsaw, Poland; November 2017.

12. Berkowitz C, Allen D, Tenhover J, Zullig L, Fischer J, Pollak K, Smith S, Ragsdale J, Anderson J, Bowlby L, Koontz B. Poster: “Bridging the Gap: PCP and Patient Needs in Head and Neck Cancer Survivor Care.” American Society for Radiation Oncology Annual Meeting. San Diego, CA; September 2017.

13. *Bosworth BB, Olsen M, McCant F, Stechuchak KM, Danus S, Crowley MJ, Goldstein KM, Zullig LL, Oddone E. Oral: “Telemedicine Cardiovascular Risk Reduction in Veterans: The CITIES trial.” HSR&D/QUERI National Meeting. Crystal City, VA; July 2017.

14. Zullig LL, Lindquist J, Smith VA, Williams CD, Weinberger M, Provenzale D, Jackson GL, Kelley MJ, Danus S, Bosworth HB. Poster: "Hypertension among Veterans Affairs colorectal cancer survivors: a matched case-control analysis.” HSR&D Career Development Award Meeting. Crystal City, VA; July 2017.

15. *Berkowitz C, Allen DH, Tenhover J, Zullig LL, Fischer JE, Pollak KI, Hicks MR, Hillson JV, Koontz BF. Poster: “Survivorship needs after head and neck cancer treatment.” American Society of Clinical Oncology Annual Meeting; Chicago, IL; June 2017.

16. *Zullig LL, Lindquist J, Smith VA, Williams CD, Weinberger M, Provenzale D, Jackson GL, Kelley MJ, Danus S, Bosworth HB. Poster: "Prevalence of cardiovascular-related comorbidities among Veterans Affairs colorectal cancer survivors: a matched case-control analysis.” AcademyHealth Annual Meeting. New Orleans, LA; June 2017.

17. Berkowitz C, Miller J, Koontz B, Tenhover J, Allen H, Zafar SY, Dolor R, Bosworth H, Zullig L. Poster:

“Primary Care Providers’ Knowledge, Needs, and Preferences for Cancer Survivorship Care Plans.” Duke Cancer Control Population Sciences Research Poster Fair. Durham, NC; May 2017.

18. Williams CD, Bullard AJ, Kelley M, Zullig L, Hintze B, Redding TI, Provenzale D. Poster: “Epidemiology

of Cancer Among Veterans.” Durham VA Health Care Center Research Week; Durham, NC; May 2017.

19. Berkowitz C, Zullig LL, Koontz BF, Smith SK. Poster: “Prescribing an app? Understanding oncology providers’ views on mobile health apps for cancer care.” The Lifecycle of Digital Health Science. 5th Annual mHealth@Duke Conference; Durham, NC; April 2017.

20. *Goldstein KM, Zullig LL, Andrews S, Grewe ME, Heisler M, Oddone EZ, Voils CI. Poster: "Women veterans’ views on the role of peer support to improve heart health.” Society of General Medicine Annual Meeting. Washington, DC; April 2017.

21. *Chung A, Stover A, Wagner L, LeBlanc T, Topalaglu U, Zafar SY, Zullig L, Smeltzer P, Basch E. Poster: "Harmonization of Patient-Reported Outcomes into EHRs at Four Cancer Hospital Outpatient Clinics for Patient Care and Quality Assessment.” American Society of Clinical Oncology Quality Care Symposium. Orlando, FL; March 2017.

2016 22. Zullig LL, Sims KJ, McNeil R, Williams C, Jackson GL, Provenzale D, Kelley MJ. Poster: “Cancer

incidence in the Veterans Affairs Health Care System: A Veterans Affairs Central Cancer Registry analysis.” Veterans Affairs Launch Pad. Washington, DC; December 2016.


Revised July 2018

15 23. *De Geest S, Zullig L, Denhaerynck K, Dobbels F. Poster: “Using insights from an international study on

practice patterns in transplantation (BRIGHT STUDY) to inform the adaptation for scalability of an efficacious adherence enhancing intervention (MAESTRO-TX STUDY).” Science of Dissemination and Implementation Annual Meeting. Washington, DC; December 2016.

24. Helmy R, Zullig LL, Dunbar-Jacob J, Hughes DA, Vrijens B, Wilson IB, De Geest S. Poster: "ESPACOMP Medication Adherence Reporting Guidelines (EMERGE): A Reactive-Delphi Study." SPINE Doctoral Day. Lausanne, Switzerland; November 2016.

25. *Oakes MM, Zullig LL, Davenport CA, Grambow SC, Bosworth HB. Poster: "Evaluating a cardiovascular

disease medication adherence program among individuals with low socioeconomic status (SES): study design and methodology.” European Society for Patient Adherence, Compliance, and Persistence (ESPACOMP) Annual Meeting. Lisbon, Portugal; November 2016.

26. *De Geest S, Zullig L, Denhaerynck K, Doubles F, and The BRIGHT Study Team. Oral: "Assessment of contextual factors hindering or promoting implementation of adherence interventions.” European Society for Patient Adherence, Compliance, and Persistence (ESPACOMP) Annual Meeting. Lisbon, Portugal; November 2016.

27. *Zullig LL, Diamantidis CJ, Bhapkar M, Barnhart H, Oakes MM, Bosworth HB, Patel UD. Poster: “Racial differences in nocturnal dipping status in diabetic kidney disease (DKD): results from the STOP-DKD Study.” American Society of Nephrology Kidney Week. Chicago, IL; November 2016.

28. *Zullig LL, Sims KJ, McNeil R, Williams C, Jackson GL, Provenzale D, Kelley MJ. Poster: “Cancer

incidence in the Veterans Affairs Health Care System: A Veterans Affairs Central Cancer Registry analysis.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Dallas, TX; September 2016.

29. Silva A, Henry E, Zullig LL, Crawford RB, Faircy-Anderson K, Klein M, Houranieh J, Tarlov E. Poster:

"Treatment patterns among men with metastatic castrate-resistant prostate cancer in the United States Veterans Affairs Health System.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Dallas, TX; September 2016.

30. Henry E, Silva A, Zullig, LL, Crawford RB, Faircy-Anderson K, Klein M, Houranieh J, Aggarwal A

Mobarek D, Graf S, Lee SP, Gill T, Lynch J. Poster: "AVAHO health services research subcommittee: A productive inter-institutional partnership.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Dallas, TX; September 2016.

31. *Zullig LL, Liang Y, Arismendez SV, Bosworth HB, Turner BJ. Poster: “Factors associated with sustained

uncontrolled hypertension in a low-income, largely Hispanic primary care cohort with diabetes.” Society of General Internal Medicine Annual Meeting. Hollywood, FL; May 2016.

32. Zafar SY, Wolf SP, Zullig LL, Shankaran V, Vlastelica L, Peppercorn J. Poster: “Do pharmacy assistance programs impact out of pocket costs for patients prescribed anticancer medications?” Duke Cancer Control Population Sciences Research Poster Fair. Durham, NC; May 2016.

33. *Zullig LL, Whitson HE, Hastings SN, Beadles C, Kravchenko J, Akushevich I, Maciejewski M. Poster: “A

systematic review of conceptual frameworks of medical complexity and new model development.” Health Care Systems Research Network Conference. Atlanta, GA; April 2016.

34. *Zullig LL, Lindquist J, Smith VA, Danus S, Weinberger M, Jackson GL, Provenzale D, Kelley MJ, Bosworth HB. Poster: “Cardiovascular and personal characteristics among Veterans Affairs colorectal cancer survivors: a retrospective matched case control analysis.” Veterans Affairs Health Services Research & Development Career Development Award Meeting. Arlington, VA; February 2016.


Revised July 2018

16 35. *Zullig LL, Muiruri M, Nyindo P, Namwai T, Karia F, Oresto M, Silayo E, Msomba A, Bartlett J, Zafar SY.

Poster: “Validation and quality assessment of the Kilimanjaro Cancer Registry.” ASCO Quality Care Symposium. Phoenix, AZ; February 2016.

36. *Check D, Reeder-Hayes KE, Basch EM, Zullig LL, Weinberger M, Dusetzina SB. Poster: "Investigating

racial disparities in use of neurokinin-1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among Medicare beneficiaries with breast cancer." ASCO Quality Care Symposium. Phoenix, AZ; February 2016.

2015 37. *Munishi MO, Nyindo P, Namwai T, Mapunda O, Mmbaga B, Israel I, Karia F, Bartlett J, Zullig LL, Muiruri C,

Zafar SY. Poster: “Most common malignancies in a tertiary hospital cancer registry in Northern Tanzania: August 2013 –Feb 2015.” African Organisation for Research & Training in Cancer. Marrakech, Morocco; November 2015.

38. Kimmick G, Shelby R, Zullig L, Robertson J, Kavesvaran R, White H. Poster: “Geriatric syndromes in older breast cancer patients detected using a brief geriatric screener.” International Society of Geriatric Oncology. Prague, Czech Republic; November 2015.

39. *Goldstein K, Stechuchak K, Zullig L, Oddone E, Olsen M, McCant F, Batch B, Bosworth H. Poster: “Gender differences in satisfaction and confidence in lipid control among high risk individuals.” Society for Women’s Health Research Symposium. Winston-Salem, NC; October 2015.

40. *Silva A, Henry E, Bhoopalam N, Gupta G, Zullig LL, Faricy-Anderson K, Crawford R, Klein MA, Cosgriff S, Mobarek D, Aggarwal A, Haggstrom D, Tarlov E. Poster: "Veterans with castration-resistant prostate cancer: characteristics and treatment.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Washington, D.C.; October 2015.

41. *Zullig LL, Smith VA, Danus S, Schnell M, Lindquist J, Provenzale D, Jackson GL, Weinberger M, Kelley

MJ, Bosworth HB. Poster: “Colorectal cancer statistics among patients reported in the Veterans Affairs Central Cancer Registry.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Washington, D.C.; October 2015.

42. *Goldstein K, Stechuchak K, Zullig L, Oddone E, Olsen M, McCant F, Batch B, Bosworth H. Poster: “Gender differences in satisfaction and confidence in lipid control among high risk Veterans.” VA HSRD/QUERI National Conference. Philadelphia, PA; July 2015.

43. Zullig LL, Schroeder K, Oresto M, Karia F, Afyusisye F, Nicolla J, Likonda B, Muiruri C, Bartlett J, Maro V, Zafar SY. Poster: “Building and evaluating cancer registry capacity in Mwanza and Moshi, Tanzania.” Duke Cancer Control Population Sciences Research Poster Fair. Durham, NC; May 2015.

44. Shaw RJ, Zullig LL, Pollak K, Bennett G, Lipkus I. Poster: “Exploring feasibility and smokers’ evaluation of

self-generated text messages to promote quitting.” Duke Cancer Control Population Sciences Research Poster Fair. Durham, NC; May 2015.

45. *Zullig LL, Stechuchak KM, Goldstein KM, Olsen MK, McCant FM, Danus S, Crowley MJ, Oddone EZ, Bosworth HB. Poster: “Patient-reported medication adherence barriers among Veterans Affairs patients with cardiovascular risk factors.” Society of General Internal Medicine Annual Meeting. Toronto, Canada; April 2015.


Revised July 2018

17 2014 46. Zullig LL, Rushing C, Chino F, Samsa G, Altomare I, Tulsky J, Ubel P, Nicolla J, Abernethy A, Peppercorn

J, Zafar SY. Poster: “Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision-making?” Duke Cancer Institute Scientific Retreat. Durham, NC; November 2014.

47. *Nipp RD, Zullig LL, Samsa G, Peppercorn JM, Schrag D, Taylor DH, Abernethy AP, Zafar SY. Poster: “Coping with cancer treatment-related financial burden.” Palliative Care in Oncology Symposium. Boston, MA; October 2014.

48. *Zullig LL, Faricy-Anderson K, Crawford R, Klein MA, Cosgriff S, Henry E, Mobarek D, Aggarwal A, Haggstrom D, Bhoopalam N. Poster: “Protocol to evaluate medication non-adherence among patients with metastatic prostate cancer.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Portland, OR; September 2014.

49. *Zullig LL, Rushing C, Chino F, Samsa G, Altomare I, Tulsky J, Ubel P, Nicolla J, Abernethy AP, Peppercorn J, Zafar SY. Poster: “Can we identify patients at risk for discordance in preferred and actual role in cancer treatment decision-making?” American Society of Clinical Oncology Annual Meeting. Chicago, IL; June 2014.

50. Munishi OM, Namwai T, Nyindo P, Mvungi S, Mapunda O, Zafar SY, Zullig LL. Poster: “Kilimanjaro Christian Cancer Registry: history, achievements and challenges.” Duke Cancer Control Research Poster Fair. Durham, NC; June 2014.

51. Zullig LL, McCant F, Melnyk SD, Danus S, Bosworth HB. Poster: “Improving medication adherence using a Meducation® health literacy intervention.” Durham Veterans Affairs Medical Center Research Week. Durham, NC; May 2014. Winner, 4th Place in Institute for Medical Research Young Investigator Poster Contest.

52. Kirshner MA, Bosworth HB, Roumie CL, Rakley SM, Kravetz JD, Del Monte PS, Bowen ME, Oddone EZ,

Weiner BJ, Shaw RJ, Zullig LL, Jackson GL. Poster: “Challenges and opportunities encountered conducting partnered research in organizational readiness to change and implementation of HTN-IMPROVE.” Durham Veterans Affairs Medical Center Research Week. Durham, NC; May 2014.

53. Zullig LL, Bosworth HB, Jeffreys AS, Corsino L, Coffman C, Oddone E, Yancy W, Allen K. Poster: “The

association of comorbid conditions with patient reported outcomes among patients with osteoarthritis.” Durham Veterans Affairs Medical Center Research Week. Durham, NC; May 2014.

54. *Zullig LL, McCant F, Melnyk SD, Danus S, Bosworth HB. Poster: “A health literacy intervention to improve medication adherence using Meducation® technology.” Society of General Internal Medicine Annual Meeting. San Diego, CA; April 2014.

55. *Goldstein KM, Melnyk SD, Zullig LL, Stechuchak KM, Oddone EZ, Bastian L, Rakley S, Olsen M, Bosworth HB. Poster: “Gender and racial differences in control of cardiovascular disease risk factors among Veterans.” Society of General Internal Medicine Annual Meeting. San Diego, CA; April 2014.

56. *Zullig LL, Bosworth HB, Jeffreys AS, Corsino L, Coffman C, Oddone E, Yancy W, Allen K. Poster: “The association of comorbid conditions with patient reported outcomes among patients with osteoarthritis.” Osteoarthritis Research Society International. Paris, France; April 2014.


Revised July 2018

18 2013 57. *Bestvina C, Zullig LL, Rushing C, Chino F, Samsa G, Altomare I, Tulsky J, Ubel P, Schrag D, Nicolla J,

Abernethy A, Peppercorn J, Zafar SY. Oral: “Patient-oncologist cost communication, financial distress, and medication adherence.” American Society of Clinical Oncology Quality Care Symposium. San Diego, CA; November 2013.

58. *Zullig LL, Vanderburg SB, Muiruri C, Bartlett J, Olola O, Zafar SY. Poster: “A qualitative assessment of sustainability of a cancer registry at a tertiary medical center in Kilimanjaro, Tanzania.” African Organisation for Research & Training in Cancer. Durban, South Africa; November 2013.

59. *Vanderburg S, Zullig LL, Muiruri C, Zafar SY, Oneko O, Bartlett JA. Oral: “Quality and sustainability in cancer registration: a systematic review of African cancer registries.” African Organisation for Research & Training in Cancer. Durban, South Africa; November 2013.

60. *Vanderburg S, Munishi MO, Muiruri C, Zullig LL, Zafar SY, Ntabaye M. Poster: “Rebuilding a cancer registry in northern Tanzania: a stepwise review of 2010-2013.” African Organisation for Research & Training in Cancer. Durban, South Africa; November 2013.

61. *Zullig LL, Jackson GL, Provenzale D, Griffin J, Phelan S, van Ryn M. Poster: “Patient-reported colorectal

cancer care coordination in the VA Healthcare System.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Atlanta, GA; October 2013.

62. Jackson GL, Zullig LL, Kelley MJ, Williams CD, Abbott D, Provenzale DT. Poster: “Measurement to

improvement: research and health system operations partnering to improve VA cancer care.” Duke Institute for Health Innovation Summit. Durham, NC; September 2013.

63. *Zullig LL, Jackson GL, Weinberger M, Provenzale D, Reeve BB, Carpenter WR. Poster: “Are there racial

differences in colorectal cancer care timeliness among users of the Veterans Affairs Healthcare System?” American Society of Clinical Oncology Annual Meeting. Chicago, IL; June 2013.

64. *Shaw RJ, Kaufman MA, Bosworth HB, Weiner BJ, Lee SD, Kravetz JD, Rakley SM, Roumie CL, Bowen ME, Del Monte PS, Oddone EZ, Zullig LL, Jackson GL. Poster: “Organizational factors associated with the effective implementation and translation of a primary care based behavioral program to improve blood pressure control: the HTN-IMPROVE study.” AcademyHealth Annual Research Meeting. Baltimore, MD; June 2013.

65. Zullig LL, Carpenter WR, Provenzale DT, Weinberger M, Reeve BB, Jackson GL. Poster: “Examining

potential cancer care quality disparities in the Veterans Affairs (VA) Healthcare System.” Lineberger Scientific Retreat. Chapel Hill, NC; May 2013. Winner, 2nd Place in Population Sciences category.

66. Zullig LL, Peppercorn J, Schrag D, Taylor D, Lu Y, Samsa G, Abernethy A, Zafar SY. Poster: “Financial

distress, cost-coping strategies, and prescription medication adherence among cancer patients.” Duke Cancer Institute Scientific Retreat. Durham, NC; May 2013.

67. Zullig LL, Carpenter WR, Provenzale D, Weinberger M, Reeve BB, Jackson GL. Poster: “Examining

potential colorectal cancer care timeliness disparities in the Veterans Affairs Healthcare System.” Durham Veterans Affairs Medical Center Research Week. Durham, NC; May 2013. Winner, 1st Place in Institute for Medical Research Young Investigator Poster Contest.


Revised July 2018

19 68. Shaw RJ, Kaufman MA, Bosworth HB, Weiner BJ, Lee SD, Kravetz JD, Rakley SM, Roumie CL, Bowen

ME, Del Monte PS, Oddone EZ, Zullig LL, Jackson GL. Poster: “Organizational factors associated with the effective implementation and translation of a primary care based behavioral program to improve blood pressure control: the HTN-IMPROVE study.” Durham Veterans Affairs Medical Center Research Week. Durham, NC; May 2013.

69. Zullig LL, Jackson GL, Provenzale D, Weinberger M, Reeve BB, Carpenter WR. Oral: “The association of

race with timeliness of care and survival among US Veterans with late stage non-small-cell lung cancer.” UNC University Research Day. Chapel Hill, NC; February 2013.

70. Zullig LL, Jackson GL, Weinberger M, Provenzale D, Reeve BB, Carpenter WR. Poster: “An examination of racial differences in timeliness of colorectal cancer care among users of the Veterans Affairs Healthcare System.” University of North Carolina Minority Health Conference. Chapel Hill, NC; February 2013.

2012 71. *Zullig LL, Peppercorn J, Schrag D, Taylor D, Zhong, X, Samsa G, Abernethy A, Zafar SY. Poster:

“Copayment assistance and adherence to prescription medication among cancer patients.” American Society of Clinical Oncology Quality Care Symposium. San Diego, CA; November 2012.

72. *Zullig LL, Carpenter WR, Abbott DH, Provenzale DT, Weinberger M, Reeve BB, Jackson GL. Poster: “Examining potential cancer care disparities in an equal access system – quality of colorectal cancer care (CRC) in the Veterans Affairs (VA) Healthcare System.” American Society of Clinical Oncology Quality Care Symposium. San Diego, CA; November 2012.

73. *Zullig LL, Carpenter WR, Abbott DH, Provenzale DT, Weinberger M, Reeve BB, Jackson GL. Poster: “Quality of colorectal cancer care in the Veterans Affairs Healthcare System – examining potential colorectal cancer disparities in an equal access system.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Omaha, NE; October 2012.

74. *Carpenter WR, Tyree S, Zullig LL, Fortune-Greeley AK, White B, DiMartino L, Godley PA. Poster: “A statewide surveillance system and web-based reporting for monitoring and improving minority access to cancer clinical trials.” Community Networks Program Centers (CNPC) Program Meeting. Bethesda, MD; July 2012.

75. *Zullig LL, Vanderburg S, Johnson D, Oneko O, Muiruri C, Ntabaye M, Abernethy AP, Bartlett J, Zafar SY. Poster: “Assessment of cancer registries (CR) in low and middle-income countries (LMCs).” American Society of Clinical Oncology Annual Meeting. Chicago, IL; June 2012.

76. *VanderWalde NA, Meyer AM, Zullig LL, Tyree SD, Carpenter WR, Weissler MC, Shores CG, Hayes DN, Chera BS. Poster: “Patterns of care in elderly patients with squamous cell carcinoma of the head and neck: a SEER-Medicare analysis.” American Society of Clinical Oncology Annual Meeting. Chicago, IL; June 2012.

77. *Bosworth HB, Weiner BL, Lee SYD, Zullig LL, Kravetz JD, Rakley SM, Roumie CL, Bowen ME, Del Monte PS, Kaufman MA, Jackson GL. Poster: “Measuring organizational readiness to change for a broadly implemented clinical program.” AcademyHealth Annual Research Meeting. Orlando, FL; June 2012.

78. Zullig LL, Jackson GL, Provenzale D, Griffin J, Phelan S, van Ryn M. Poster: “Patient-reported cancer care coordination in the Veterans Affairs Healthcare System.” University of North Carolina Lineberger Comprehensive Cancer Center Scientific Retreat. Chapel Hill, NC; May 2012.

79. Zullig LL, Jackson GL, Provenzale D, Griffin J, Phelan S, van Ryn M. Poster: “Patient-reported cancer care coordination in an integrated healthcare system.” Spotlight on Student Research Day. Chapel Hill, NC; April 2012.


Revised July 2018

20 80. Zullig LL, Jackson GL, Provenzale DT, Griffin J, Phelan S, van Ryn M. Poster: “Transportation – a vehicle

or roadblock to cancer care for VA colorectal cancer patients?” UNC University Research Day. Chapel Hill, NC; March 2012. Honorable mention for social science poster award.

81. Zullig LL, Provenzale DT, McNeil RB, Abbott D, Jackson GL. Poster: “Equity in an equal access system: the

effect of race on receipt of guideline-concordant surveillance colonoscopy.” University of North Carolina Minority Health Conference. Chapel Hill, NC; February 2012.

2011 82. *Vanderburg S, Zafar SY, Zullig LL, Oneko O, Muriuri C, Ntabaye M. Oral: “Cancer registries in Africa: a

local issue of global significance.” African Organisation for Research & Training in Cancer. Cairo, Egypt; November 2011.

83. *Zullig LL, Provenzale DT, McNeil RB, Abbott D, Jackson GL. Oral: “The effect of race on receipt of

guideline-concordant surveillance colonoscopy.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Kansas City, MO; October 2011.

84. *Godley PA, Carpenter WR, Edwards LJ, Talcott JA, Zullig LL, Peacock S, Schenck AP. Poster: “Efficacy

of PSA screening for prostate cancer: a case-control study of Caucasian and African American Medicare beneficiaries.” American Association for Cancer Research International Conference on the Science of Cancer Health Disparities. Washington, DC; September 2011.

85. *Carpenter WR, Tyree S, Meyer A, Wu Y, DiMartino LD, Zullig LL, Corbie-Smith G, Godley PA. Poster:

“Increasing cancer clinical trial enrollment in North Carolina communities.” National Cancer Institute Center to Reduce Cancer Health Disparities Program Meetings. Rockville, MD; July 2011.

86. *Zullig LL, Jackson GL, Provenzale DT, Griffin J, Phelan S, van Ryn M. Poster: “Transportation – a vehicle

or roadblock to cancer care for VA colorectal cancer patients?” AcademyHealth Annual Research Meeting. Seattle, WA; June 2011. Semifinalist for AcademyHealth Student Poster Award.

87. Zullig LL, Carpenter WR. Poster: “Organizational factors associated with patient accrual into community-

based cancer clinical trials.” University of North Carolina Lineberger Comprehensive Cancer Center Scientific Retreat. Chapel Hill, NC; May 2011. Winner, 3rd Place in Population Sciences category.

88. Beadles C, Zullig LL. Poster: “Effectiveness of methods of oral anticoagulation management as measured by

time in target range: a systematic review and meta-analysis.” Chapel Hill Drug Conference. Chapel Hill; May 2011.

89. *Provenzale DT, Jackson GL, van Ryn M, Zullig LL, Ordin DL, Clauser SB. Poster: “VA cancer quality

improvement initiatives-research infrastructure.” National Cancer Institute Conference: Multilevel Interventions in Health Care. Las Vegas, NV; March 2011.

90. *Jackson GL, Ordin DL, Zullig LL, Khwaja R, Powell AA, van Ryn M, Clauser SB, Provenzale DT. Poster:

“Development and utilization of colorectal cancer care quality measures in an integrated delivery system.” National Cancer Institute Conference: Multilevel Interventions in Health Care. Las Vegas, NV; March 2011.

91. Zullig LL, Hilliard T, Beadles C, Ellis S, Dilworth-Anderson P. Poster: “An examination of disparities in

acute stroke care among African Americans in NC.” University of North Carolina Minority Health Conference. Chapel Hill, NC; February 2011.


Revised July 2018

21 2010 92. *Zullig LL, Jackson GL, Griffin J, Jindal RM, Clausner S, Han P, Haggstrom D, Zafar SY, Arora N, Stahre

M, Phelan S, Provenzale DP, van Ryn M. Oral: “The C-CARES survey: a new instrument to assess quality of care and communication patterns in colorectal cancer patients in the Veterans Affairs Healthcare System.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Little Rock, AR; October 2010.

2009 93. *Provenzale DP, Jackson GL, Zullig LL, Paynter BK, Khwaja R, Gellad ZF, Ordin D. Poster: “The

colorectal cancer quality measurement system (CCQMS).” Digestive Disease Week. Chicago, IL; June 2009. 94. *Jackson GL, Melton LD, Abbott D, Zullig LL, Ordin DL, Grambow SC, Hamilton NS, Zafar SY, Gellad

ZF, Provenzale D. Poster: “Linking practice guidelines and abstraction of electronic medical record data to measure the quality of cancer care.” AcademyHealth Annual Research Meeting. Chicago, IL; June 2009.

95. *Zafar SY, Grambow SC, Abbott DH, Malin JL, Zullig LL, Kolimaga JT, Provenzale DT, and the CanCORS

Steering Committee. Poster: “Factors associated with chemotherapy receipt and intensity for stage IV colorectal cancer (CRC): a multi-health system, population-based study.” American Society of Clinical Oncology National Meeting. Orlando, FL; May 2009.

96. *Fisher DA, Zullig LL, Grambow SC, Abbott DH, Provenzale DT. Poster: “Determinants of time to

diagnosis of colorectal cancer in the VA system.” Health Services Research & Development National Meeting. Baltimore, MD; February 2009.

97. *Zullig LL, Jackson GL, Paynter BK, Khwaja R, Powell AA, Ordin DL, Gellad ZF, Zafar SY, Hamilton NS,

Newlin CB, Provenzale DT. Poster: “Colorectal cancer patient refusal of adjuvant chemotherapy by stage of disease.” Health Services Research & Development National Meeting. Baltimore, MD; February 2009.

98. *Zafar SY, Grambow SC, Abbott DH, Schrag D, Zullig LL, Kolimaga JT, Weeks JC, Provenzale D. Poster:

“Access to bevacizumab for first-line metastatic colorectal cancer: a Cancer Outcomes Research & Surveillance Consortium (CanCORS) study.” Health Services Research & Development National Meeting. Baltimore, MD; February 2009.

99. Hamilton NS, Jackson GL, Abbott DH, Paynter B, Zullig LL, Ordin DL, Provenzale DT. Poster: “Use of

psychosocial support services at diagnosis among patients with colorectal cancer in the VA.” University of North Carolina Minority Health Conference. Chapel Hill, NC; February 2009.

2008 100. *Jackson GL, Powell AA, Zullig LL, Provenzale DT. Oral: “Developing and sustaining quality

improvement partnerships in the VA: the Colorectal Cancer Care Collaborative.” Quality Enhancement Research Initiative National Meeting. Phoenix, AZ; December 2008.

101. *Zullig LL, Jackson GL, Paynter BK, Khwaja R, Powell AA, Ordin DL, Gellad ZF, Zafar SY, Hamilton

NS, Newlin CB, Provenzale DT. Poster: “Colorectal cancer patient refusal of chemotherapy by stage of disease.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Nashville, TN; September 2008.

102. *Jackson GL, Zullig LL, Paynter B, Khwaja R, Powell AA, Ordin DL, Zafar Y, Gellad ZF, Newlin CB,

Hamilton NS, Provenzale DT. Oral: “Measuring the quality of colorectal cancer care in the Veterans Health Administration.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Nashville, TN; September 2008.


Revised July 2018

22 103. *Zafar SY, Grambow SC, Abbott DH, Schrag D, Kolimaga JT, Zullig-Conner L, Weeks JC, Provenzale

DT. Poster: “Use of bevacizumab after U.S. Food and Drug Administration (FDA) approval for first-line metastatic colorectal cancer (mCRC): a Cancer Outcomes Research & Surveillance Consortium (CanCORS) study.” American Society of Clinical Oncology Annual Meeting. Chicago, IL; June 2008.

104. *Fisher DA, Zullig-Conner L, Grambow SC, Abbott DH, Provenzale DT. Poster: “Time to diagnosis of

colorectal cancer in the VA System.” Digestive Disease Week. San Diego, CA; May 2008. 2007 105. Provenzale DT, Jackson GL, Zullig-Conner L. Oral: “CRC treatment improvement collaborative: cancer

care quality measurement system.” Colorectal Cancer Care Collaborative (C4) Learning Session 2. Las Vegas, NV; October 2007.

106. Zullig-Conner L, Jackson GL, Paynter BK, Khwaja R, Powell AA, Ordin DL, Gellad ZF, Zafar SY,

Hamilton NS, Newlin CB, Provenzale DT. Oral: “Development of a cancer care quality measurement system: A VA research-operations partnership.” Association of Veterans Affairs Hematology & Oncology Annual Meeting. Washington, DC; September 2007.

107. *Zafar SY, Abernethy AP, Abbott DH, Herndon JE, Rowe K, Kolimaga JT, Zullig-Conner L,

Patwardhan MB, Grambow SC, Provenzale DT. Poster: “Comorbidity, age and stage at diagnosis in colorectal cancer (CRC).” American Society of Clinical Oncology. Chicago, IL; June 2007.

108. Jackson GL, Zullig-Conner L, DT Provenzale. Oral: “Colorectal cancer care collaborative: role of

research partners.” Colorectal Cancer Care Collaborative (C4) Learning Session 1. San Antonio, TX; April 2007.

109. Jackson GL, Khwaja R, Paynter BK, Zafar SY, Powell AA, Ordin DL, Garrett MM, Gellad ZF, Newlin

CB, Zullig-Conner L, Czarnecki T, Provenzale DT. Poster: “Development of a cancer care quality measurement system: a VA research-operations partnership.” Duke Comprehensive Cancer Center Annual Meeting. Durham, NC; March 2007.

INVITED PRESENTATIONS Local 1. Zullig, LL. Oral: “Colorectal Cancer Survivorship & Cardiovascular Disease in the Veterans Affairs

Healthcare System.” University of North Carolina Department of Pharmaceutical Outcomes and Policy Seminar Series. Chapel Hill, NC; February 14, 2018.

2. Zullig, LL. Oral: “GOAL: Using a Geriatric Oncology Assessment to Link with Services.” Duke Multiple Chronic Conditions and Patient Complexity Special Interest Group. Durham, NC: October 19, 2017.

3. Zullig LL, Goldstein KM. Oral: “Informing a National Breast Cancer Navigation Program: Improving Cancer Care Quality & Coordination for Women Veterans.” VetREP Veterans Engagement Panel. Durham, NC: October 18, 2017.

4. Zullig LL, Crowley M. Oral: “Theoretically Speaking: Intervention Mapping at the Pre-Clinical Phase.”

Duke Pepper Center for Aging, Intervention Mapping Workshop. Durham, NC: September 22, 2017.

5. Maciejewski, ML, Zullig LL. Oral: “What is Complexity and How can we Measure It?” Duke Multiple Chronic Conditions and Patient Complexity Special Interest Group. Durham, NC: January 1, 2017.


Revised July 2018

23

6. Zullig, LL. Oral: “Building and evaluating cancer registry capacity in Moshi and Mwanza, Tanzania.” Durham VA Health Services Research and Development (HSR&D) Research Conference. Durham, NC: June 28, 2016.

7. Zullig, LL. Oral: “Works in progress.” Duke Division of General Internal Medicine Faculty and Fellows Seminar Series. Durham, NC: January 9, 2015.

8. Zullig, LL. Oral: “Building and evaluating cancer registry capacity in Moshi and Mwanza, Tanzania.” Duke Global Cancer Working Group Meeting. Durham, NC: December 18, 2014.

9. Zullig, LL. Oral: “Self-report medication adherence measures: examples in cardiovascular disease & cancer.”

Comparative Effectiveness Research Strategic Initiative, NC TraCS, Chapel Hill, NC; May 9, 2014.

National 1. Zullig, LL. Oral: “Cancer survivorship and cardiovascular disease.” National VA Cyberseminar. November

14, 2017.

2. Haggstrom D, Zullig LL, Silva A. Oral: “VA Health Services Research & Development and the Career Development Award Program.” Association of VA Hematology and Oncology Annual Meeting. Denver, CO: September 15, 2017.

3. Zullig, LL. Oral: “Pinpointing bottlenecks within the patient journey.” Patient Journey Mapping: From Diagnosis to Treatment. Philadelphia, PA: August 15, 2016.

4. McNeil R, Sims K, Zullig L, Jackson G, Provenzale D. Oral: “Two case studies of statistical approaches that simplify the VHA learning healthcare system.” Joint Statistical Meetings. Chicago, IL: July 31, 2016.

5. Zullig, LL. Oral: “Medication nonadherence: are there effective interventions that can address this costly, preventable and potentially deadly behavior?” OptumHealth Education 9th Annual Medical Director Forum. Las Vegas, NV: November 5, 2015.

6. Zullig, LL. Oral: “Design, evaluation, implementation of adherence interventions.” Medication Adherence

Alliance Think Tank. McClean, VA: January 14, 2015. 7. Zullig, LL. Oral: “Shared decision-making and financial burden: does cost matter?” The Business of Cancer

Care: Measuring Outcomes, American Society of Clinical Oncology Annual Meeting. Chicago, IL; May 30, 2014.

LEADERSHIP ROLES IN PROFESSIONAL EDUCATION

1. Zullig LL, De Geest S, van Dijk L, Foster J, van den Bemt. Workshop: “Writing effective specific aims and objectives for dissemination and implementation science.” European Society for Patient Adherence, Compliance, and Persistence (ESPACOMP) Annual Meeting. Budapest, Hungary; November 30, 2017. Role: Workshop designer.

2. Zullig LL, Bosworth HB. Summer Short Course: “Dissemination and Implementation Science: An Intensive Primer.” School of Nursing, University Basel (Switzerland) and University of Leuven (Belgium). Basel, Switzerland; May-August 2017. Role: Course designer and co-teacher.


Revised July 2018

24

3. Zullig LL, De Geest S, van Dijk L, Foster J, van den Bemt. Workshop: “Adaption of interventions: how to translate existing intervention to your own setting – a practical guide.” European Society for Patient Adherence, Compliance, and Persistence (ESPACOMP) Annual Meeting. Lisbon, Portugal; November 17, 2016. Role: Workshop designer and lead.

4. Zullig LL, Leader A. Workshop: “Inaugural Israeli hematology-oncology medication adherence conference.” Tel-Aviv, Israel; September 25-26, 2016. Role: Workshop co-designer and co-leader.

5. Zullig LL, de Bruin M, van den Bemt B, van Dijk L, Schneider MP, De Geest S. Workshop: “Adopting and implementing evidence based adherence interventions in diverse clinical settings.” European Society for Patient Adherence, Compliance, and Persistence (ESPACOMP) Annual Meeting. Prague, Czech Republic; November 12, 2015. Role: Workshop co-designer and lead.

6. Zullig LL, Kaufmann P, Lee K. Panel: “So simple, so hard: taking medication as directed.” National Consumers League-Script Your Future Conference. Sacramento, CA; September 15, 2015. Role: Panelist.

7. Zullig LL, De Geest S, van Dijk L, de Bruin M, van den Bemt B, Schneider MP. Workshop: “Development, implementation and evaluation of large system, scalable adherence interventions.” European Society for Patient Adherence, Compliance, and Persistence (ESPACOMP) Annual Meeting. Lausanne, Switzerland; November 20, 2014. Role: Workshop co-designer and lead.

PROFESSIONAL DEVELOPMENT

1. Duke Department of Medicine Faculty Development Academy. Durham, NC; 2016-2017.

2. Mentored Training for Dissemination and Implementation Research in Cancer (MT-DIRC). St. Louis, MO; 2015-2016.

3. Duke LEADER: Leadership Development for Researchers. Durham, NC; February 24-26, 2015.

TEACHING ACTIVITIES

2017 Lecturer, University of North Carolina, Department of Health Policy and Management. HPM 886- Advanced Health Services Research Methods and Applications. PhD level course. (3 credit hours) Focuses on applications of research methods that are relevant to health services and health policy researchers.

2015 Guest Lecturer, Duke University, Department of Medicine and Global Health, Durham,

NC. Presented “Building and evaluating cancer registry capacity in Moshi and Mwanza, Tanzania.” Lecture for graduate level course addressing chronic diseases in low- and middle-income countries.

2015 Guest Lecturer, Central College, Pella, IA. Presented “The life aquatic” to undergraduate

students in a freshman seminar series.


Revised July 2018

25 2013, 2014 Guest Lecturer, Duke University, Department of Medicine and Global Health, Durham,

NC. Presented “Summiting the cancer registration peak: cancer registry development in Moshi Tanzania.” Lecture for graduate level course addressing non-communicable diseases in low- and middle-income countries.

2012 Guest Lecturer, Kilimanjaro Christian Medical Center, Moshi, Tanzania. Presented

“Responsible Conduct in Research.” Lecture for select physicians, medical students, and trainees conducting human or laboratory research at KCMC.

2012 Guest Lecturer, University of North Carolina, Department of Health Policy and

Management, Chapel Hill, NC. Presented “Equity in an equal access system – quality & timeliness of cancer care in the VA.” Lecture for HPM 873–Research Seminar in Health Policy and Management.

2009 Guest Lecturer, University of North Carolina, Department of Health Policy and

Management, Chapel Hill, NC. Presented “Taking an oral history.” Lecture for HPM 351–Policy Issues in Health Services Delivery.

2009–2010 Teaching Assistant, University of North Carolina, Department of Health Policy and

Management, Chapel Hill, NC. HPM 600–Introduction to Health Policy and Management. Provides an overview of the United States health system, emphasizing the role of policy development and administrative decision making through case examples.

MENTORING ACTIVITIES Doctoral Dissertation Committee Member 1. Alecia Clary (2017-Current): “As the Gap Grows: Racial Disparities in Cancer Care Quality in the VA Health

Care System.” University of North Carolina. Chapel Hill, NC. Role: Committee member

2. Remon Helmy (2015-Current): “Scalability of adherence-enhancing interventions in transplantation: Optimizing measurement, contextual analysis, intervention development and development of reporting guidelines for medication-adherence research.” University of Basel. Basel, Switzerland. Role: Committee member

3. Charles Muiruri (2016-2017): “Quality of cardiovascular disease care in HIV infected persons.” University of

North Carolina. Chapel Hill, NC. Role: Committee member

4. Sarah Lewis (2015-2016): “Assessing quality of non-cancer chronic care and medication adherence for comorbidities among men with prostate cancer.” University of North Carolina. Chapel Hill, NC. Role: Committee member

5. Devon Karnes Check (2015-2016): “Assessing racial disparities in quality of chemotherapy-induced side

effect management among Medicare beneficiaries with early stage breast cancer.” University of North Carolina. Chapel Hill, NC. Role: Committee member

Junior Faculty Mentoring 6. Okeke, Lance (2016-Current): “A Multidisciplinary Approach to Primary Cardiovascular Disease Prevention

among HIV-infected Persons.” Duke University. Durham, NC. Role: Secondary mentor, K23


Revised July 2018

26

7. Onala Telford (2016-2018): “The prevalence of diabetes and pre-diabetes in eastern Kazakhstan.” Duke University. Durham, NC. Role: Secondary mentor, unfunded junior faculty research project

8. Semvua, Seleman. (2016-2017): “Investigating effect of Patient-Initiated Repackaging of Antiretroviral Therapy (ART) on Adherence and viral suppression in Northern Tanzania.” Kilimanjaro Christian Medical College. Moshi, Tanzania. Role: Secondary mentor, NIH training grant supplementary project

Medical Student Mentoring 9. Callie Berkowitz (2016-2017): “Optimizing Cancer Survivorship Care Plans.” Duke University. Durham, NC. 10. Sky Vanderburg (2013-2014): “Cancer Registration in Low and Middle Income Countries.” Duke University.

Durham, NC. Undergraduate Mentoring 11. Christiana Oshotse (2016-2017): “Treatment Engagement and Adherence.” Duke University. Durham, NC. RESEARCH SUPPORT Active Support CDA (13-025) Zullig (PI) 08/2014-07/2019 VA HSR&D $633,414 Colorectal Cancer Survivorship Care in the Veterans Affairs Healthcare System The objective of the CDA-2 is to improve VA CRC survivors’ care quality through a self-management intervention bridging cancer surveillance and chronic disease management. These objectives will be fulfilled through three aims: (1) to construct and characterize a national cohort of VA CRC survivors and their self-management behaviors, with a similar non-cancer comparison group; (2) to assess VA CRC survivors’ self-management perceptions; and (3) to design and pilot-test an intervention motivating VA CRC survivors’ adherence to survivorship self-management. Role: Principal Investigator 1R21CA217268-01A1 Vasudevan (PI) 7/1/2018-6/30/2020 NIH $326,807 An mHealth case management system for reducing pediatric cancer treatment abandonment This study develops a mobile health based case management platforms to facilitate pediatric cancer treatment compliance in Tanzania. 1R21MD012465-01 Zullig (co-PI) 09/2017-06/2019 NIH $235,541 Disparities in care of prostate cancer survivors, a population-based cohort study This study examines receipt of guideline-recommended survivorship care and racial disparities in care through an innovative linkage of a novel population-based, prospective cohort of prostate cancer survivors (The North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study [NC ProCESS]) to administrative and claims data from multiple private and public insurance plans and healthcare systems. SDR (15-236) Kimbrel (PI) 01/2017-12/2020 VA HSR&D $1,061,227 Healthcare Utilization Patterns and Associated Costs for Gulf War I Era Veterans The objective of this project is to learn firsthand about Gulf Ware I era Veteran’s experiences with both VA and non-VA healthcare through the use of electronic health record data, a telephone-based survey, and focus groups. Role: Co-Investigator


Revised July 2018

27 Duke Institute for Brain Sciences Lin (PI) 05/2018-08/2019 Bass Connections $25,000 Patients’ Journey to Medication Adherence: Renewal This is a renewal with separate funding of our project to engage undergraduate students in research and to provide insight into patient psychology regarding optimal medication adherence. This project will focus on understanding patients’ perceptions regarding rheumatoid arthritis medication use via focus groups and qualitative interviews. Role: Co-Investigator Past Support Duke Institute for Brain Sciences Lin (PI) 01/2017-04/2018 Bass Connections $24,830 Patients’ Journey to Medication Adherence The objective of this projects is to engage undergraduate students in research and to provide insight into patient psychology regarding optimal medication adherence. This project will focus on understanding patients’ feelings and thought processes regarding medication use via focus groups and qualitative interviews. Role: Co-Investigator Duke Cancer Institute Zullig (PI) 07/2016-06/2018 DCI CCPS $25,000 Assessing Primary Care Providers' Knowledge/ Needs, and Preferences for Cancer Survivorship Care Plans The objective of the qualitative study is to understand key stakeholders’ informational needs and delivery preferences related to head and neck cancer survivorship care plans. Role: Principal Investigator Maciejewski & Zulman (Co-PIs) 06/2016-09/2017 PACT Demo Lab Initiative $269,238 Interconnected Factors that Influence Health, Experiences and Needs (IF-THEN) Study The goal of this project is to conduct a survey on 10,000 high risk Veterans to understand self-reported factors of complexity. Role: Co-Investigator 3D43TW009595-04S1 Bartlett (PI) 10/2016-09/2017 NIH Fogarty International $101,234 Investigating effect of Patient-Initiated Repackaging of Antiretroviral Therapy (ART) on Adherence and viral suppression in Northern Tanzania The objectives of this study are to describe the prevalence of patient-initiated repackaging of antiretroviral therapy in two large care and treatment centers in Northern Tanzania and to evaluate the impact of patient-initiated repackaging on adherence to antiretroviral therapy and on virological failure. Role: Co-Investigator CCR11603 Zafar (PI) 06/2016-06/2017 CTSA $75,000 Harmonization of Patient-Reported Outcomes Across Three CTSAs: Leveraging EHRs to Enable Comparative Effectiveness Research to Improve the Quality of Cancer Care The objective of this collaborative project between Duke, Wake Forest, and the University of North Carolina at Chapel Hill is to integrate and harmonize patient reported outcomes into clinical cancer care across three electronic health records. Role: Co-Investigator


Revised July 2018

28 PhRMA Foundation Bosworth (PI) 07/2015-06/2017 PhRMA Foundation $117,000 Evaluating CVD Medication Adherence Program in Low SES The objective is to evaluate the implementation of an efficacious medication adherence program combining interactive technology with a telephonic self-management program in patients with low resources at high risk for cardiovascular disease (CVD). Role: Co-Investigator NIH CA014236 Zullig (PI) 06/2016-05/2017 NIH Sub-award $50,000 Using a Geriatric Oncology Assessment to Link with Services (GOAL) The objective of GOAL is to implement a brief geriatric oncology assessment in a community-based oncology clinic in Laurinburg, NC. The brief assessment will be used to identify patients’ unmet need and link them with appropriate community-based services. Role: Principal Investigator 5P30DK096493-02 Zullig (PI) 04/2014-04/2016 NIH Sub-award $54,300 Ambulatory Blood Pressure Measurement Among Patients with Diabetic Kidney Disease and Hypertension This is a sub-award under Duke University’s prime award from the National Institutes of Health. Through the Duke O’Brien Center for Kidney Research, we will obtain ambulatory blood pressure baseline measurements to further inform the randomized control STOP-DKD trial. The overarching objective of the study is to measure ambulatory blood pressure at baseline in order to understand subclinical cardiovascular disease risk and how it differs by race. Role: Principal Investigator Pilot Project Zullig (PI) 01/2015-12/2015 Duke Global Cancer $40,000 Building and Evaluating Cancer Registry Capacity in Moshi and Mwanza, Tanzania The objective of this pilot project is to evaluate the quality of existing data in the Kilimanjaro Christian Medical Center cancer registry, while simultaneously building infrastructure to support the development of an additional hospital-based cancer registry in at Bugando Medical Center in Mwanza, Tanzania. Role: Principal Investigator 1D43-CA153722 Bartlett (PI) 09/2010-8/2013 National Cancer Institute $460,134 Developing Research Capacity in Africa for Studies on HIV-Associated Malignancies grant's major focus has been on providing training and research opportunities to future Tanzanian HIV Associated Malignancies investigators. These efforts build substantially on the initial investments for HIV/AIDS and its infectious complications. Role: Investigator 5R25CA116339 Leatt (PI) 05/2011-04/2013 National Cancer Institute $490,408 The Cancer Care Quality Training Program (CCQTP) trains clinical and non-clinical scientists to work in multidisciplinary research teams to improve cancer care quality across the cancer care continuum. CCQTP provides fellows with hands-on research experience and mentoring from faculty members from diverse disciplines and incorporates a specialized curriculum that involves tailored coursework and an immersion experience in tumor board meetings. Role: Pre-doctoral Trainee


Revised July 2018

29 PROFESSIONAL SERVICE Local 2017– Deputy Director, PhD Post-Doctoral Fellowship Program, Durham VA Advanced Fellowship Program in Health Services Research and Development 2015–2018 Durham Veterans Affairs Medical Center Institutional Review Board 2013– Alumni Representative, PhD Program Advisory Committee, University of North Carolina,

Department of Health Policy and Management; Chapel Hill, NC. 2013 Masters Thesis Presentation Moderator, University of North Carolina, Department of Health

Policy and Management; Chapel Hill, NC. 2013 Health Policy and Management Student Representative, University of North Carolina, School of

Public Health Recruitment Day; Chapel Hill, NC. 2011 Graduate School Program Review Committee, University of North Carolina, Department of

Health Policy and Management; Chapel Hill, NC. 2010–2013 Student Representative, PhD Program Advisory Committee, University of North Carolina,

Department of Health Policy and Management; Chapel Hill, NC. 2010 Team-Based Learning Evaluation Committee, University of North Carolina, Department of

Health Policy and Management; Chapel Hill, NC. National 2016– VA CanCORS Scientific and Ethical Oversight Committee (SEOC) 2015– Honorary Editorial Board Member, Patient Preference and Adherence 2013–2015 Health Services Research Committee Chair, Association of Veterans Affairs Hematology and

Oncology Association 2013– Research Committee Member, Association of Veterans Affairs Hematology and Oncology

Association 2017 Abstract Reviewer, VA Health Services Research & Development National Meeting 2017 Secretary and Board Member, Association of Veterans Affairs Hematology and Oncology

Association International 2016– Steering Committee, European Society for Patient Adherence, Compliance, and Persistence

(ESPACOMP) 2016 Development Committee, ESPACOMP Medication Adherence Reporting Guidelines (EMERGE)

(Husafell, Iceland) 2016 Abstract Reviewer, ESPACOMP Annual Meeting (Lisbon, Portugal) 2016 Panel Session Moderator, ESPACOMP Annual Meeting (Lisbon, Portugal) 2017 Panel Session Moderator, Duke-National University of Singapore Bridging Symposium

(Singapore) 2017 Abstract Reviewer, ESPACOMP Annual Meeting (Budapest, Hungary) AD-HOC JOURNAL REVIEWER American Heart Journal, Cancer Medicine, Cancer Treatment and Research Communications, Circulation: Cardiovascular Quality and Outcomes, Current Pharmaceutical Design, International Journal for Quality in Health Care, JCO Clinical Cancer Informatics, Journal of Clinical Hypertension, Journal General Internal Medicine, Journal of Managed Care & Specialty Pharmacy, Journal of Nephrology, Journal of Oncology Practice, Journal of Telemedicine and Telecare, International Journal of Women's Health, Medical Care, North Carolina Medical Journal, Patient Preference and Adherence, PLOS ONE, Preventing Chronic Disease, Psycho-Oncology, Research in Social and Administrative Pharmacy, The Journal of Clinical Hypertension, Translational Behavioral Medicine, Women’s Health Issues


Revised July 2018

30 AD-HOC GRANT REVIEWER 2015 Louisiana Board of Regents 2017 Yorkshire Cancer Research 2017 National Medical Research Council, Singapore Ministry of Health

leah l. zullig - unc gillings school of global public health · leah l. zullig 411 west chapel hill...

Documents